SIGMA-SYSTEMS
1.5.2019 10:39:07 CEST | Business Wire | Press release
Sigma Systems, the global leader in catalog-driven software is pleased to announce its acquisition by Hansen Technologies, a leader in billing, data management and customer care solutions for the Energy, Water, Pay-TV, and Telecommunications industries. Upon closing of the sale, Hansen will acquire full ownership of Sigma Systems. Hansen Technologies is a publicly traded company listed on the Australian Stock Exchange (ASX:HSN).
In today’s highly disruptive environment, service providers are focusing on how to accelerate product and service innovation, transforming their businesses into digital organizations that can more effectively create new innovative offerings, sell them without friction in the customer’s channel of choice, and deliver those services as promised. From digital service innovation through to revenue realization and customer support, the acquisition of Sigma and the resulting combined product offerings of the two companies will further strengthen and expand the value proposition across the Telecom, Media, IoT, Energy and Utilities industries we serve. The combination of these two fast-growing companies creates an even stronger organization with greater expertise, a deeper bench of talented delivery specialist, expanded R&D scale and a broader diversification of our business across industry verticals.
Andrew Hansen, Chief Executive Officer of Hansen Technologies , commented: “It’s with great enthusiasm that I welcome Sigma Systems to the Hansen Technologies Group. The acquisition represents a strategic move to enhance our value proposition to the telecom, pay-tv and energy verticals. Over the course of the last ten years, we have driven an exceptional growth strategy through acquisitions, achieving a compound annual growth rate of 28% over the last 4 years. Bringing Sigma Systems onboard further strengthens our ability to provide valuable solutions to our customer base and creates new expansion opportunities to cross-sell Sigma’s software solutions into our broad base of energy customers.”
Tim Spencer, Chief Executive Officer of Sigma Systems , commented: “With over a 23-year history serving the needs of the telecom industry, it is with great pride that we move to the next chapter in Sigma’s history. In the last year, Sigma has been pursuing an aggressive growth strategy through increased focus on product and cloud adoption, growth through adjacent verticals, and an enhanced go-to-market partner strategy. The acquisition of Sigma by Hansen Technologies represents two strong companies coming together, a strong combined value proposition, and the acceleration of the Sigma strategy. We look forward to the new opportunities in front of us to drive value for Sigma and Hansen customers and shareholders of the company.”
The acquisition of Sigma Systems is set to close on May 31, 2019. For further information about Sigma Systems, its award-winning products and services, and getting Next Done Now visit www.sigma-systems.com or contact us at info@sigma-systems.com .
For further information about Hansen Technologies visit www.hansencx.com .
About Sigma Systems (sigma-systems.com or Twitter @SigmaSystems)
Sigma Systems is the global leader in catalog-driven software solutions for communications, media, and high-tech companies. It serves over 80 customers in 40 countries with its award-winning products. The company’s portfolio spans enterprise-wide Catalog, Configure Price Quote (CPQ), Order Management, Provisioning, Insights and Portfolio Inventory products, and offers a core set of services including professional services, cloud services, and managed services. Sigma utilizes an agile approach to implementing its B/OSS products for its customers. Sigma has offices in North and South America, Europe and Asia Pacific, with technology and integration partners globally.
About Hansen Technologies
Hansen Technologies is a global leader in billing, data management and customer care. With over 40 years’ experience, Hansen Technologies Group employs over 1000 experts. Hansen’s proven and scalable solutions as well as innovative and flexible offerings, enable more than 500 clients to deliver cost-effective end-to-end business initiatives to improve their customers’ experience.
Hansen has offices throughout the world in Denmark, Finland, Norway, Sweden, Germany, Netherlands, Australia, New Zealand, China, Argentina, South Africa and in the USA servicing customers in over 80 countries. www.hansencx.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190501005429/en/
Contact:
Adnan Bashir Senior Corporate Communications Manager Sigma Systems +1 647 204 0999 Chloe Purcell Head of PR Milner Strategic Marketing Ltd. +44 1473 633123
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom